SEC. 2. FINDINGS. 
Congress finds the following: 
(1) Stomach cancer accounts for about 1.5 per-
cent of all new cancers diagnosed in the United 
States each year. 
(2) It is estimated that there will be nearly 
30,300 new cases of stomach cancer in 2025. 
(3) There are disparities in stomach cancer in-
cidence and mortality among racial and ethnic 
groups in the United States. 
(4) While there has been a decline in stomach 
cancer incidence, the lack of awareness and focus on 
risk factors and early detection through screening 
and surveillance may cause individuals at high risk 
for the disease to dismiss their symptoms. 
(5) Establishing a basis for stomach cancer 
prevalence, awareness, current screening, and impli-
cations for future public health importance will allow 
for— 
(A) more effective outreach and screening 
among individuals at risk; 
(B) increased awareness and education 
among the general public to prevent stomach 
cancer; and 
(C) increased awareness and education 
among health care providers regarding gastric 
VerDate Sep 11 2014 
03:48 Aug 05, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4841.IH
H4841
kjohnson on DSK7ZCZBW3PROD with $$_JOB
cancer disparities, screening, treatment, and 
monitoring. 
SEC. 3. NCI REVIEW ON CURRENT STATE OF STOMACH CAN-
CER INCIDENCE, PREVENTION, SCREENING, 
AWARENESS, AND FUTURE PUBLIC HEALTH 
IMPORTANCE. 
(a) REVIEW.—The Director of the National Cancer 
Institute shall conduct a review of— 
(1) the current incidence of stomach cancer in 
the United States; 
(2) the risk factors for stomach cancer, includ-
ing the incidence of such risk factors among high- 
risk populations and the general public; 
(3) the optimal age range to test for and treat 
Helicobacter pylori (H. pylori) infection, as a risk 
factor, for the purpose of primary prevention in 
high-risk populations and the general population; 
(4) the availability and frequency of screening 
for stomach cancer, including utilization and effec-
tiveness, among high-risk populations; 
(5) 
the 
availability 
and 
effectiveness 
of 
endoscopic screenings in high-risk populations; 
(6) 
the 
availability 
and 
effectiveness 
of 
endoscopic resection and surveillance endoscopy for 
patients with confirmed gastric intestinal metaplasia 
VerDate Sep 11 2014 
03:48 Aug 05, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4841.IH
H4841
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(GIM) with high-grade dysplasia and early gastric 
cancer; 
(7) the benefits of surveillance endoscopy for 
patients at elevated risk, including patients with gas-
tric intestinal metaplasia (GIM) who are at in-
creased risk of gastric cancer due to ethnic back-
ground, family history, or other risk stratification 
parameters such as smoking and H. pylori infection; 
(8) current awareness and education about 
stomach cancer risk factors, prevention, symptoms, 
screening, and treatment options among high-risk 
populations and the general public; and 
(9) current Federal efforts to increase aware-
ness and education of stomach cancer among high- 
risk populations and the general public. 
(b) REPORT.—Not later than 18 months after the 
date of enactment of this Act, the Director of the National 
Cancer Institute shall— 
(1) submit to the Congress a report on the re-
sults of the review under subsection (a); and 
(2) include in such report recommendations 
for— 
(A) establishing a clear definition of high- 
risk populations in the United States; 
VerDate Sep 11 2014 
03:48 Aug 05, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4841.IH
H4841
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(B) informing researchers, clinicians, phy-
sicians, patients, and other relevant stake-
holders on— 
(i) identifying high-risk individuals; 
and 
(ii) effective methods for detecting 
precancerous lesions and early gastric can-
cer; 
(C) establishing routine screening guide-
lines for stomach cancer; and 
(D) actions to improve research on, pre-
vention and early diagnosis of, and screening 
and treatment for stomach cancer. 
SEC. 4. DEPARTMENT OF DEFENSE STUDY ON STOMACH 
CANCER 
INCIDENCE 
AND 
RISK 
FACTORS 
AMONG MILITARY PERSONNEL. 
(a) STUDY.—The Secretary of Defense, in coordina-
tion with the Director of the National Cancer Institute 
and the Director of the Centers for Disease Control and 
Prevention, shall conduct a study on the incidence, risk 
factors, prevention, and early detection of stomach cancer 
among members of the Armed Forces and former mem-
bers of the Armed Forces. 
(b) ELEMENTS.—The study under subsection (a) 
shall include— 
VerDate Sep 11 2014 
03:48 Aug 05, 2025
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H4841.IH
H4841
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(1) an examination of— 
(A) the incidence, prevalence, and mor-
tality rates of stomach cancer among members 
of the Armed Forces serving on active duty and 
former members of the Armed Forces who 
served on active duty; 
(B) the identification of service-related or 
deployment-related risk factors, including expo-
sure to burn pits, hazardous chemicals, con-
taminated water, occupational hazards, and en-
demic infections such as Helicobacter pylori (H. 
pylori); 
(C) disparities in stomach cancer outcomes 
based on race, ethnicity, gender, Armed Force, 
or geographic deployment history within mili-
tary populations; 
(D) the availability and use of stomach 
cancer screening, diagnostic, and treatment 
services within the military health system and 
the health system of the Department of Vet-
erans Affairs; and 
(E) opportunities to improve prevention 
and early detection strategies within the mili-
tary health system and the health system of the 
Department of Veterans Affairs; and 
VerDate Sep 11 2014 
03:48 Aug 05, 2025
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4841.IH
H4841
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(2) relevant coordination with the Surveillance, 
Epidemiology, and End Results Program and other 
national cancer registries to ensure comprehensive 
data collection and analysis. 
(c) REPORT.—Not later than 18 months after the 
date of the enactment of this Act, the Secretary of Defense 
shall submit to Congress a report on the findings of the 
study under subsection (a), including— 
(1) policy and programmatic recommendations 
to reduce stomach cancer incidence and mortality 
among members of the Armed Forces and former 
members of the Armed Forces; and 
(2) proposed strategies for integrating stomach 
cancer awareness, screening, and treatment proto-
cols into the military health system and the health 
system of the Department of Veterans Affairs. 
Æ 
VerDate Sep 11 2014 
03:48 Aug 05, 2025
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H4841.IH
H4841
kjohnson on DSK7ZCZBW3PROD with $$_JOB